Improving decay-accelerating factor (DAF, CD55) by substituting a GPI-anchor with a membrane-targeting address

被引：0
|
作者：
White, J
Giddings, N
Esser, D
Thurston, K
Steward, M
Bright, JR
Morgan, BP
Smith, GP
Smith, RAG
机构：
[1] AdProTech, Saffron Walden CB10 1XL, Essex, England
[2] Univ Wales Coll Med, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales
来源：
MOLECULAR IMMUNOLOGY | 2001年 / 38卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
131
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [1] Progesterone Receptors Signaling and Upregulation of Decay-Accelerating Factor (DAF/CD55)
    Ansley, Ariel J.
    Rana, Tanu
    Nowicki, Stella
    Nowicki, Bogdan
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 135S - 136S
  • [2] DECAY-ACCELERATING FACTOR (DAF, CD55) IN NORMAL COLORECTAL MUCOSA, ADENOMAS AND CARCINOMAS
    KORETZ, K
    BRUDERLEIN, S
    HENNE, C
    MOLLER, P
    BRITISH JOURNAL OF CANCER, 1992, 66 (05) : 810 - 814
  • [3] CRYSTALLOGRAPHIC STUDIES OF DECAY-ACCELERATING FACTOR (CD55)
    Lukacik, P.
    Billington, J.
    Heinrich, A.
    Thurston, K.
    Smith, G.
    White, J.
    Smith, R. A.
    Lea, S. M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C281 - C281
  • [4] STRUCTURE AND FUNCTION OF DECAY-ACCELERATING FACTOR CD55
    NICHOLSONWELLER, A
    WANG, C
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (04): : 485 - 491
  • [5] Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex
    Heine, H
    Ulmer, AJ
    El-Samalouti, VT
    Lentschat, A
    Hamann, L
    JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (03): : 227 - 231
  • [6] DEFICIENCY OF COMPLEMENT DECAY-ACCELERATING FACTOR (DAF, CD55) IN NON-HODGKINS-LYMPHOMA
    FUKUDA, H
    SEYA, T
    HARA, T
    MATSUMOTO, M
    KINOSHITA, T
    MASAOKA, T
    IMMUNOLOGY LETTERS, 1991, 29 (03) : 205 - 210
  • [7] Complement decay accelerating factor (DAF)/CD55 in cancer
    Spendlove, I
    Ramage, JM
    Bradley, R
    Harris, C
    Durrant, LG
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (08) : 987 - 995
  • [8] Complement decay accelerating factor (DAF)/CD55 in cancer
    Ian Spendlove
    Judith M. Ramage
    Richard Bradley
    Claire Harris
    Lindy G. Durrant
    Cancer Immunology, Immunotherapy, 2006, 55 : 987 - 995
  • [9] Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor
    Martino, TA
    Peric, M
    Brown, M
    Aitken, K
    Gauntt, CJ
    Richardson, CD
    Chow, LH
    Liu, PP
    VIROLOGY, 1998, 244 (02) : 302 - 314
  • [10] Decay-accelerating factor (CD55) deficiency phenotypes in Japanese
    Daniels, GL
    Green, CA
    Mallinson, G
    Okubo, Y
    Hori, Y
    Kataoka, A
    Kaihara, M
    TRANSFUSION MEDICINE, 1998, 8 (02) : 141 - 147
12345